Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Duchenne Muscular Dystrophin (DMD)”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Testing effectiveness (Phase 2)Study completedNCT00159250
What this trial is testing

Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy

Who this might be right for
Duchenne Muscular Dystrophy
Imperial College London 7
Very early researchStudy completedNCT06594094
What this trial is testing

An Open-label, Multidose Dose-escalation Study to Understand the Safety of CRISPR Gene-editing Therapy and Its Long-Lasting Effects in DMD Patients (MUSCLE)

Who this might be right for
Duchenne Muscular Dystrophin (DMD)
HuidaGene Therapeutics Co., Ltd. 4
Testing effectiveness (Phase 2)Study completedNCT03218995
What this trial is testing

Study of Eteplirsen in Young Participants With Duchenne Muscular Dystrophy (DMD) Amenable to Exon 51 Skipping

Who this might be right for
Duchenne Muscular Dystrophy
Sarepta Therapeutics, Inc. 15
Testing effectiveness (Phase 2)Ended earlyNCT04004065
What this trial is testing

Two-Part Study for Dose Determination of Vesleteplirsen (SRP-5051) (Part A), Then Dose Expansion (Part B) in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51-Skipping Treatment

Who this might be right for
Duchenne Muscular Dystrophy
Sarepta Therapeutics, Inc. 62
Testing effectiveness (Phase 2)Study completedNCT02286947
What this trial is testing

Safety Study of Eteplirsen to Treat Advanced Stage Duchenne Muscular Dystrophy

Who this might be right for
Muscular Dystrophy, Duchenne
Sarepta Therapeutics, Inc. 24
Testing effectiveness (Phase 2)Looking for participantsNCT05753462
What this trial is testing

Phase 1/2a for Safety, PK and PD of SQY51 in Paediatric and Adult Patients Duchenne Muscular Dystrophy

Who this might be right for
Duchenne Muscular Dystrophy
Sqy Therapeutics 12
Testing effectiveness (Phase 2)Study completedNCT03375164
What this trial is testing

A Gene Transfer Therapy Study to Evaluate the Safety of Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)

Who this might be right for
Duchenne Muscular Dystrophy
Sarepta Therapeutics, Inc. 4
Early research (Phase 1)Study completedNCT00005574
What this trial is testing

Gentamicin Treatment of Muscular Dystrophy

Who this might be right for
Becker Muscular DystrophyDuchenne Muscular Dystrophy
National Institute of Neurological Disorders and Stroke (NINDS) 4
Not applicableAvailableNCT07250737
What this trial is testing

Managed Access Program for Del-zota in Participants With DMD Mutations Amenable to Exon 44 Skipping

Who this might be right for
Muscular Disorders, AtrophicMuscular DiseasesMusculoskeletal Diseases+6 more
Avidity Biosciences, Inc.
Not applicableStudy completedNCT03879304
What this trial is testing

Effectiveness of a Multimodal Physiotherapy Program With Virtual Reality Glasses in Duchenne and Becker.

Who this might be right for
Muscular Dystrophy, Duchenne and Becker Types
University of Malaga 12
Testing effectiveness (Phase 2)Study completedNCT03796637
What this trial is testing

Assess Dystrophin Levels in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD) Who Have Been Treated With Ataluren

Who this might be right for
Duchenne Muscular Dystrophy
PTC Therapeutics 6
Large-scale testing (Phase 3)Ended earlyNCT03917719
What this trial is testing

An Open-Label Extension Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy

Who this might be right for
Duchenne Muscular Dystrophy
Catabasis Pharmaceuticals 130
Early research (Phase 1)Study completedNCT00428935
What this trial is testing

Safety Study of Mini-dystrophin Gene to Treat Duchenne Muscular Dystrophy

Who this might be right for
Duchenne Muscular Dystrophy
Nationwide Children's Hospital 6
Not applicableUnknownNCT02020954
What this trial is testing

Prospective Becker-Heart-Study

Who this might be right for
Dilated CardiomyopathyLef Ventricular DysfunctionHeart Failure
Karim WAHBI 100
Very early researchLooking for participantsNCT07188012
What this trial is testing

Safety and Dystrophin Expression of SPOT-mRNA03 in Duchenne Muscular Dystrophy (DMD) Patients

Who this might be right for
Duchenne Muscular Dystrophy (DMD)
Shanghai Siponuoyin Biotechnology Co Ltd 6
Testing effectiveness (Phase 2)Ended earlyNCT03985878
What this trial is testing

Evaluate Safety, Tolerability, and Efficacy of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) Who Have Completed Study 4658-102 (NCT03218995)

Who this might be right for
Duchenne Muscular Dystrophy
Sarepta Therapeutics, Inc. 15
Early research (Phase 1)Ended earlyNCT03362502
What this trial is testing

Evaluate the Safety and Tolerability of PF-06939926 Gene Therapy in Duchenne Muscular Dystrophy

Who this might be right for
Duchenne Muscular Dystrophy
Pfizer 23
Not applicableEnrolling By InvitationNCT05715957
What this trial is testing

Follow-up Study on Female Carriers With DMD Gene Variants

Who this might be right for
Muscular DystrophyDuchenne Muscular DystrophyBecker Muscular Dystrophy
Rigshospitalet, Denmark 103
Testing effectiveness (Phase 2)WithdrawnNCT06833931
What this trial is testing

PGN-EDO51 or Placebo in People With Duchenne Muscular Dystrophy Amenable to Exon 51-Skipping Treatment

Who this might be right for
Duchenne Muscular Dystrophy (DMD)
PepGen Inc
Testing effectiveness (Phase 2)Looking for participantsNCT07287189
What this trial is testing

Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients

Who this might be right for
Duchenne Muscular DystrophyDuchenneDMD+2 more
Satellos Bioscience, Inc. 51
Load More Results